发明名称 PYRIMIDINE DERIVATIVE AS MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY
摘要 PROBLEM TO BE SOLVED: To provide specific heterocyclic compounds, production methods, intermediates and intermediates usable for the production thereof, pharmaceutical compositions containing the same, and use of the composition in treatment. SOLUTION: Compounds of formula (1) (wherein, each symbol is specifically defined), pharmaceutically acceptable salts, solvates and in vivo hydrolyzable esters thereof, have activity as pharmaceuticals, in particular as modulators of chemokine receptor (especially CXCR2) activity, and are usable in the treatment (therapeutic or prophylactic) of conditions/diseases in human and non-human animals, which are exacerbated or caused by excessive or unregulated production of chemokines. COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011052025(A) 申请公布日期 2011.03.17
申请号 JP20100282057 申请日期 2010.12.17
申请人 ASTRAZENECA AB 发明人 EBDEN MARK RICHARD;MEGHANI PREMJI;COOK ANTONY RONALD;STEELE JOHN;CHEEMA LAL LASHKAR SINGH
分类号 C07D239/46;A61K31/505;A61K31/506;A61P1/04;A61P1/16;A61P3/10;A61P5/14;A61P9/10;A61P11/00;A61P11/06;A61P11/08;A61P13/12;A61P17/00;A61P17/14;A61P19/02;A61P19/08;A61P19/10;A61P25/00;A61P25/06;A61P25/14;A61P25/28;A61P29/00;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D239/56;C07D239/60;C07D401/04;C07D401/12;C07D403/12;C07D413/04;C07D413/12;C07D413/14;C07D417/12 主分类号 C07D239/46
代理机构 代理人
主权项
地址